-
1
-
-
33846841180
-
Amelioration of dextran sulfate sodium-induccd colitis in mice by oral administration of beta-caryophyllene, a sesquiterpene
-
Cho JY, Chang HJ, Lee SK, et al. Amelioration of dextran sulfate sodium-induccd colitis in mice by oral administration of beta-caryophyllene, a sesquiterpene. Life Sci 2007; 80: 932-939.
-
(2007)
Life Sci
, vol.80
, pp. 932-939
-
-
Cho, J.Y.1
Chang, H.J.2
Lee, S.K.3
-
2
-
-
0035085024
-
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study
-
Bernstein C, Blanchard J, Houston D, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85: 430-434.
-
(2001)
Thromb Haemost
, vol.85
, pp. 430-434
-
-
Bernstein, C.1
Blanchard, J.2
Houston, D.3
-
3
-
-
0022656226
-
Vascular complications of inflammatory bowel disease
-
Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61: 140-145.
-
(1986)
Mayo Clin Proc
, vol.61
, pp. 140-145
-
-
Talbot, R.W.1
Heppell, J.2
Dozois, R.R.3
-
4
-
-
84941818179
-
Venous thrombosis occurring in non-specific ulcerative colitis
-
Graef V, Baggenstoss AH, Seaur WG. Venous thrombosis occurring in non-specific ulcerative colitis. Arch Intern Med 1966; 117: 377-382.
-
(1966)
Arch Intern Med
, vol.117
, pp. 377-382
-
-
Graef, V.1
Baggenstoss, A.H.2
Seaur, W.G.3
-
5
-
-
0012449340
-
Chronic inflammatory lesions of the small intestine (regional enteritis)
-
Brown PW, Bargen J, Weber HA. Chronic inflammatory lesions of the small intestine (regional enteritis). Am J Dig Dis 1934; 1: 426-431.
-
(1934)
Am J Dig Dis
, vol.1
, pp. 426-431
-
-
Brown, P.W.1
Bargen, J.2
Weber, H.A.3
-
6
-
-
0024445939
-
Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction
-
Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2: 1057-1062.
-
(1989)
Lancet
, vol.2
, pp. 1057-1062
-
-
Wakefield, A.J.1
Sawyerr, A.M.2
Dhillon, A.P.3
-
7
-
-
0028949781
-
Inherited disorders of coagulation appear to protect against inflammatory bowel disease
-
Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995; 108: 1011-1015.
-
(1995)
Gastroenterology
, vol.108
, pp. 1011-1015
-
-
Thompson, N.P.1
Wakefield, A.J.2
Pounder, R.E.3
-
8
-
-
0034746960
-
Low molecular weight heparin treatment in steroid refractory ulcerative colitis: Clinical outcome and influence on mucosal capillary thrombi
-
Vrij AA, Jansen JM, Schoon EJ, et al. Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi. Scand J Gastroenterol 2001; Suppl: 41-47.
-
(2001)
Scand J Gastroenterol
, Issue.SUPPL.
, pp. 41-47
-
-
Vrij, A.A.1
Jansen, J.M.2
Schoon, E.J.3
-
9
-
-
0028814834
-
Paradoxical response to heparin in 10 patients with ulcerative colitis
-
Gaffney PR, Doyle CT, Gaffney A, et al. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 1995; 90: 220-223.
-
(1995)
Am J Gastroenterol
, vol.90
, pp. 220-223
-
-
Gaffney, P.R.1
Doyle, C.T.2
Gaffney, A.3
-
10
-
-
0032847644
-
Low molecular weight heparin as adjuvant therapy in active ulcerative colitis
-
Torkvist L, Thorlacius H, Sjoqvist U, et al. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1323-1328.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 1323-1328
-
-
Torkvist, L.1
Thorlacius, H.2
Sjoqvist, U.3
-
11
-
-
0032975985
-
Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease
-
Folwaczny C, Wiebecke B, Loeschke K. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol 1999; 94: 1551-1555.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 1551-1555
-
-
Folwaczny, C.1
Wiebecke, B.2
Loeschke, K.3
-
12
-
-
11144358357
-
Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis
-
Bloom S, Kiilerich S, Lassen MR, et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther 2004; 19: 871-878.
-
(2004)
Aliment Pharmacol Ther
, vol.19
, pp. 871-878
-
-
Bloom, S.1
Kiilerich, S.2
Lassen, M.R.3
-
13
-
-
0034672363
-
Spontaneous thrombosis in mice carrying the factor V Leiden mutation
-
Cui J, Eitzman DT, Westrick RJ, et al. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood 2000; 96: 4222-4226.
-
(2000)
Blood
, vol.96
, pp. 4222-4226
-
-
Cui, J.1
Eitzman, D.T.2
Westrick, R.J.3
-
14
-
-
33748110996
-
Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice
-
Bruggemann LW, Schoenmakers SH, Groot AP, et al. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice. Crit Care Med 2006; 34: 2201-2206.
-
(2006)
Crit Care Med
, vol.34
, pp. 2201-2206
-
-
Bruggemann, L.W.1
Schoenmakers, S.H.2
Groot, A.P.3
-
15
-
-
0035210979
-
Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice
-
Ten Hove T, Corbaz A, Amitai H, et al. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterology 2001; 121: 1372-1379.
-
(2001)
Gastroenterology
, vol.121
, pp. 1372-1379
-
-
Ten Hove, T.1
Corbaz, A.2
Amitai, H.3
-
16
-
-
0036149971
-
Contrasting roles of IL-12p4O and IL-12p35 in the development of hapten-induced colitis
-
Camoglio L, Juffermans NP, Peppelenbosch M, et al. Contrasting roles of IL-12p4O and IL-12p35 in the development of hapten-induced colitis. Eur J Immunol 2002; 32: 261-269.
-
(2002)
Eur J Immunol
, vol.32
, pp. 261-269
-
-
Camoglio, L.1
Juffermans, N.P.2
Peppelenbosch, M.3
-
17
-
-
0028314865
-
Mutation in blood coagulation factor V associated with resistance to activated protein C
-
Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
-
(1994)
Nature
, vol.369
, pp. 64-67
-
-
Bertina, R.M.1
Koeleman, B.P.2
Koster, T.3
-
18
-
-
4243738904
-
Resistance to activated protein C due to a factor V gene mutation: The most common inherited risk factor of thrombosis
-
Zöller B, Holm J, Dahlbäck B. Resistance to activated protein C due to a factor V gene mutation: The most common inherited risk factor of thrombosis. Trends Cardiovasc Med 1996: 6: 45-53.
-
(1996)
Trends Cardiovasc Med
, vol.6
, pp. 45-53
-
-
Zöller, B.1
Holm, J.2
Dahlbäck, B.3
-
19
-
-
33845369571
-
Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden
-
Couturaud F, Kearon C, Leroyer C, et al.; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. Thromb Haemost 2006; 96: 744-749.
-
(2006)
Thromb Haemost
, vol.96
, pp. 744-749
-
-
Couturaud, F.1
Kearon, C.2
Leroyer, C.3
-
20
-
-
0036124011
-
Factor V and thrombotic disease: Description of a janus-faced protein
-
Nicolaes GA, Dahlback B. Factor V and thrombotic disease: description of a janus-faced protein. Arterioscler Thromb Vasc Biol 2002; 22: 530-538.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 530-538
-
-
Nicolaes, G.A.1
Dahlback, B.2
-
21
-
-
0038606814
-
Review article: Inherited thrombophilia in inflammatory bowel disease
-
Papa A, Danese S, Grillo A, et al. Review article: inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 2003; 98: 1247-1251.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 1247-1251
-
-
Papa, A.1
Danese, S.2
Grillo, A.3
-
22
-
-
0032732001
-
An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease
-
Haslam N, Standen GF, Probert CS. An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11: 1289-1291.
-
(1999)
Eur J Gastroenterol Hepatol
, vol.11
, pp. 1289-1291
-
-
Haslam, N.1
Standen, G.F.2
Probert, C.S.3
-
23
-
-
15644374039
-
Thrombophilia and inflammatory bowel disease: Does factor V mutation have a role?
-
Over HH, Ulgen S, Tuglular T, et al. Thrombophilia and inflammatory bowel disease: does factor V mutation have a role? Eur J Gastroenterol Hepatol 1998; 10: 827-829.
-
(1998)
Eur J Gastroenterol Hepatol
, vol.10
, pp. 827-829
-
-
Over, H.H.1
Ulgen, S.2
Tuglular, T.3
-
24
-
-
0033768784
-
Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency
-
Egger B, BaJaj-Elliott M, MacDonald TT, et al. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000; 62: 240-248.
-
(2000)
Digestion
, vol.62
, pp. 240-248
-
-
Egger, B.1
BaJaj-Elliott, M.2
MacDonald, T.T.3
|